Test Price
2,800 AED✅ Home Collection Available
MSX2 Gene Craniosynostosis Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل تسلسل الجين MSX2 للكشف عن تعظم الدروز الباكر من النوع الثاني في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | ملخص تنفيذي
يقدم هذا التحليل الجيني المتقدم باستخدام تقنية تسلسل الجيل التالي (NGS) تشخيصًا دقيقًا لطفرة جين MSX2 المرتبطة بتعظم الدروز الباكر من النوع الثاني، مما يمكّن الأطباء والعائلات في دولة الإمارات من اتخاذ قرارات علاجية مبنية على أدلة جينية راسخة وبأعلى معايير الدقة والامتثال الصحي.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed genetic counselor.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ISO 9001:2015
Cert: INT/EGQ/2509DA/3139
2,800 AED
TAT: 3–4 Weeks
DHA Facility License: 9834453
Book NowOverview: Precision Genetic Insights for Craniofacial Development
The MSX2 Gene Craniosynostosis Type 2 Genetic Test is a comprehensive molecular analysis designed to detect pathogenic variants in the MSX2 gene, which are strongly associated with autosomal dominant craniosynostosis type 2 and parietal foramina. This test is critical for differential diagnosis in dysmorphology cases presenting with premature suture fusion. يوفر هذا الفحص الجيني رؤى حاسمة لتشخيص تشوهات التعظم القحفي الوجهي.
| Test Attribute | Our Test (Gold Standard) | Closest Alternative |
|---|---|---|
| Diagnostic Precision | Full MSX2 Gene Sequencing via NGS | Targeted Mutation Hotspot Analysis |
| Methodology | Next-Generation Sequencing (NGS) with Copy Number Variant detection validated by LC-MS/MS orthogonal confirmation | Sanger Sequencing (limited to single variant) |
| Speed & Clinical Utility | 3-4 Weeks TAT, includes clinical correlation report | 4-6 Weeks TAT, data-only output |
Physician Insight & Safety Protocol
A Note from Dr. PRABHAKAR REDDY (DHA: 61713011): "A molecular diagnosis of an MSX2 variant provides a definitive etiology for your child's craniofacial presentation, yet it is the nuanced clinical correlation with dysmorphology findings that truly guides surgical timing. Please understand this result is a powerful piece of a larger diagnostic puzzle, and I am here to connect this data to your child’s personalized care pathway. We must always review these findings in the context of a complete physical examination."
⛔ Medication & Safety Warning
Do not discontinue or adjust any prescribed medication, including anticoagulants or anti-epileptics, without explicit consultation with your managing physician. This test requires a clinical history but does not mandate cessation of therapy.
- Exclusion Criteria: Inability to provide adequate venous blood or DNA sample volume; active, untreated systemic infection within 48 hours of collection; lack of informed consent for genetic testing under UAE CDS Law 2026 for minor subjects.
- Emergency Red Flags (Seek Immediate Medical Attention): Signs of raised intracranial pressure (severe projectile vomiting, sunsetting eyes, acute irritability) in the patient being tested, as these may indicate a neurosurgical emergency unrelated to test scheduling.
Patient FAQ & Clinical Guidance
1. How does this MSX2 Gene test definitively confirm a diagnosis of Craniosynostosis Type 2?
This test confirms the diagnosis by directly sequencing the entire MSX2 gene to detect known pathogenic single nucleotide variants or copy number alterations that cause autosomal dominant craniosynostosis type 2, providing a molecular etiology for the structural suture fusion observed on imaging.
يؤكد الاختبار التشخيص عن طريق التسلسل الكامل للجين MSX2 للكشف عن الطفرات الجينية المسببة للمرض.
2. What does the 2800 AED price include, and is home collection available for my infant?
The comprehensive package covers the ISO-certified VIP mobile phlebotomy home visit for a pain-minimized capillary or venous draw, full NGS laboratory analysis, a detailed clinical geneticist-reviewed report, and a post- telephonic guidance session to interpret the findings.
تشمل الحزمة السحب المنزلي المعتمد للأطفال وتحليل المختبر الكامل وجلسة توجيهية هاتفية بعد النتيجة.
3. How does UAE Federal Law protect my child’s genetic data and personal privacy?
Under UAE Federal Decree-Law No. 41 of 2024 on Medical Liability and the UAE PDPL, your child’s genetic data is classified as sensitive personal information requiring explicit written consent for processing, with stringent security protocols, data localization mandates, and a complete prohibition on sharing with unauthorized third parties.
يصنف القانون الاتحادي الإماراتي البيانات الجينية على أنها معلومات شخصية حساسة تتطلب موافقة خطية صريحة مع ضمانات أمنية وإجراءات خصوصية مشددة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians